Italia markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
121,73+0,16 (+0,13%)
Al 2:43PM EDT. Mercato aperto.

Abbott Laboratories

100 Abbott Park Road
Abbott Park
North Chicago, IL 60064-6400
United States
224 667 6100

SettoreMedical Devices
Impiegati a tempo pieno109.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Miles D. White M.B.A.Exec. Chairman4,41MN/D1955
Mr. Robert B. FordPres, CEO & Director5,05MN/D1974
Mr. Robert E. Funck Jr.Exec. VP of Fin. & CFO2,43M8,13M1961
Mr. Hubert L. AllenExec. VP, Gen. Counsel & Sec.1,82MN/D1966
Mr. Daniel Gesua Sive SalvadoriExec. VP of Nutritional Products1,69M2,76M1979
Mr. John F. GinascolExec. VP of Core Diagnostics1,68M8,42M1959
Mr. Gregory A. AhlbergSr. VP of Core Laboratory Diagnostics & Commercial OperationsN/DN/D1967
Mr. Scott Michael LeinenweberVP of Investor Relations, Licensing & AcquisitionsN/DN/D1972
James E. YoungVP and Chief Ethics & Compliance OfficerN/DN/DN/D
Ms. Melissa BrotzVP of Public Affairs & Corp. MarketingN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.

Governance aziendale

L'ISS Governance QualityScore di Abbott Laboratories al 1 luglio 2021 è 5. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 9; diritti degli azionisti: 2; retribuzione: 4.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.